341 related articles for article (PubMed ID: 18330919)
1. PharmGKB and the International Warfarin Pharmacogenetics Consortium: the changing role for pharmacogenomic databases and single-drug pharmacogenetics.
Owen RP; Altman RB; Klein TE
Hum Mutat; 2008 Apr; 29(4):456-60. PubMed ID: 18330919
[TBL] [Abstract][Full Text] [Related]
2. The PharmGKB: integration, aggregation, and annotation of pharmacogenomic data and knowledge.
Hodge AE; Altman RB; Klein TE
Clin Pharmacol Ther; 2007 Jan; 81(1):21-4. PubMed ID: 17185992
[TBL] [Abstract][Full Text] [Related]
3. The education potential of the pharmacogenetics and pharmacogenomics knowledge base (PharmGKB).
Owen RP; Klein TE; Altman RB
Clin Pharmacol Ther; 2007 Oct; 82(4):472-5. PubMed ID: 17713470
[TBL] [Abstract][Full Text] [Related]
4. Warfarin sensitivity and genetic polymorphisms: should pharmacokinetic screening be part of anticoagulant dosing decisions?
Baglin TP
Clin Adv Hematol Oncol; 2003 Nov; 1(11):656-7. PubMed ID: 16258463
[No Abstract] [Full Text] [Related]
5. A resource to acquire and summarize pharmacogenetics knowledge in the literature.
Rubin DL; Carrillo M; Woon M; Conroy J; Klein TE; Altman RB
Stud Health Technol Inform; 2004; 107(Pt 2):793-7. PubMed ID: 15360921
[TBL] [Abstract][Full Text] [Related]
6. PharmGKB: the pharmacogenetics and pharmacogenomics knowledge base.
Thorn CF; Klein TE; Altman RB
Methods Mol Biol; 2005; 311():179-91. PubMed ID: 16100408
[TBL] [Abstract][Full Text] [Related]
7. Overview of pharmacogenetics in anticoagulation therapy.
Hill CE; Duncan A
Clin Lab Med; 2008 Dec; 28(4):513-24. PubMed ID: 19059059
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenomics and warfarin therapy.
Ndegwa S
Issues Emerg Health Technol; 2007 Oct; (104):1-8. PubMed ID: 17912794
[TBL] [Abstract][Full Text] [Related]
9. PharmGKB, an Integrated Resource of Pharmacogenomic Knowledge.
Gong L; Whirl-Carrillo M; Klein TE
Curr Protoc; 2021 Aug; 1(8):e226. PubMed ID: 34387941
[TBL] [Abstract][Full Text] [Related]
10. The extraction of pharmacogenetic and pharmacogenomic relations--a case study using PharmGKB.
Buyko E; Beisswanger E; Hahn U
Pac Symp Biocomput; 2012; ():376-87. PubMed ID: 22174293
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenomics and the management of oral anticoagulation.
Wittkowsky AK
Curr Hematol Rep; 2004 Sep; 3(5):363-7. PubMed ID: 15341704
[TBL] [Abstract][Full Text] [Related]
12. An XML-based interchange format for genotype-phenotype data.
Whirl-Carrillo M; Woon M; Thorn CF; Klein TE; Altman RB
Hum Mutat; 2008 Feb; 29(2):212-9. PubMed ID: 17994540
[TBL] [Abstract][Full Text] [Related]
13. CYP2C9 and oral anticoagulation therapy with acenocoumarol and warfarin: similarities yet differences.
Takahashi H; Wilkinson GR; Padrini R; Echizen H
Clin Pharmacol Ther; 2004 May; 75(5):376-80. PubMed ID: 15116049
[No Abstract] [Full Text] [Related]
14. Warfarin resistance with poor CYP2C9 activity and CYP2C9*1*2 genotype.
Dericioglu N; Babaoglu MO; Saygi S; Bozkurt A; Yasar U
Ann Pharmacother; 2004 May; 38(5):899. PubMed ID: 15039471
[No Abstract] [Full Text] [Related]
15. PharmGKB: the Pharmacogenomics Knowledge Base.
Thorn CF; Klein TE; Altman RB
Methods Mol Biol; 2013; 1015():311-20. PubMed ID: 23824865
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacogenetics in practice].
Spigset O
Tidsskr Nor Laegeforen; 2008 Aug; 128(15):1679. PubMed ID: 18720559
[No Abstract] [Full Text] [Related]
17. Warfarin: a case history in pharmacogenetics.
Hall AM; Wilkins MR
Heart; 2005 May; 91(5):563-4. PubMed ID: 15831631
[TBL] [Abstract][Full Text] [Related]
18. From pharmacogenomic knowledge acquisition to clinical applications: the PharmGKB as a clinical pharmacogenomic biomarker resource.
McDonagh EM; Whirl-Carrillo M; Garten Y; Altman RB; Klein TE
Biomark Med; 2011 Dec; 5(6):795-806. PubMed ID: 22103613
[TBL] [Abstract][Full Text] [Related]
19. PharmGKB: understanding the effects of individual genetic variants.
Sangkuhl K; Berlin DS; Altman RB; Klein TE
Drug Metab Rev; 2008; 40(4):539-51. PubMed ID: 18949600
[TBL] [Abstract][Full Text] [Related]
20. Avoiding overanticoagulation: pharmacogenomics or pragmatism?
Baglin T
Thromb Haemost; 2001 May; 85(5):945-6. PubMed ID: 11372698
[No Abstract] [Full Text] [Related]
[Next] [New Search]
